Sponsor Pipeline

mAbxience Research S.L. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
3
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06596772 A Study to Compare Efficacy, Pharmacokinetics, Safety and Immunogenicity of MB04… Rheumatoid Arthritis (RA) Recruiting
NCT07221734 Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus… Advanced (Unresectable or Metastatic) Melanoma Recruiting
NCT06687369 A Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB12… Non Squamous Non Small Cell Lung Cancer Recruiting
Disease Areas
Rheumatoid Arthritis (1) Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Melanoma (1)
Get alerts when mAbxience Research S.L.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free